H.R. 9699 (IH) - Drug Deal Disclosure Act - BILLS-119hr9699ih | Content Details

H.R. 9699 (IH) - Drug Deal Disclosure Act

Action: Ms. Chu (for herself, Ms. Castor of Florida, Ms. Lee of Pennsylvania, Mr. Pappas, Mr. Beyer, Ms. Clarke of New York, Ms. DelBene, Mr. Carson, Ms. Dexter, Mr. Doggett, Mr. Evans of Pennsylvania, Ms. Goodlander, Ms. Matsui, Ms. McCollum, Ms. Moore of Wisconsin, Mr. Mfume, Ms. Norton, Mr. Panetta, Ms. Ross, Ms. Schakowsky, Mr. Schneider, Mr. Takano, Ms. Tlaib, and Ms. Williams of Georgia) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

Full Title: To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.

Cosponsors: Kathy Castor (FL); Summer L. Lee (PA); Chris Pappas (NH); Donald S. Beyer, Jr. (VA); Yvette D. Clarke (NY); Suzan K. DelBene (WA); Andre Carson (IN); Maxine Dexter (OR); Lloyd Doggett (TX); Dwight Evans (PA); Maggie Goodlander (NH); Doris O. Matsui (CA); Betty McCollum (MN); Gwen Moore (WI); Kweisi Mfume (MD); Eleanor Holmes Norton (DC); Jimmy Panetta (CA); Deborah K. Ross (NC); Janice D. Schakowsky (IL); Bradley Scott Schneider (IL); Mark Takano (CA); Rashida Tlaib (MI); Nikema Williams (GA)

Committees: Committee on the Budget (Standing), Committee on Energy and Commerce (Standing), Committee on Ways and Means (Standing)

United States Code Reference: 42 U.S.C. 1320a-7b, 1395, 1396, 18031 and 247d-6b